AMRX
Amneal Pharmaceuticals, Inc. Class A Common StockNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$4.08B
P/E Ratio
58.18
EPS
$0.22
Beta
1.32
52W High
$15.42
52W Low
$7.02
50-Day MA
$12.96
200-Day MA
$11.53
Dividend Yield
—
Profit Margin
2.39%
Forward P/E
6.30
PEG Ratio
—
About Amneal Pharmaceuticals, Inc. Class A Common Stock
Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company is headquartered in Bridgewater, New Jersey.
Fundamentals
| Revenue (TTM) | $3.02B |
| Gross Profit (TTM) | $1.13B |
| EBITDA | $644.27M |
| Operating Margin | 14.10% |
| Return on Equity | -881.00% |
| Return on Assets | 7.32% |
| Revenue/Share (TTM) | $9.63 |
| Book Value | $-0.23 |
| Price-to-Book | 105.45 |
| Price-to-Sales (TTM) | 1.35 |
| EV/Revenue | 2.143 |
| EV/EBITDA | 10.71 |
| Quarterly Earnings Growth (YoY) | 261.00% |
| Quarterly Revenue Growth (YoY) | 11.50% |
| Shares Outstanding | $319.00M |
| Float | $176.28M |
| % Insiders | 44.04% |
| % Institutions | 49.64% |
Historical Volatility
HV 10-Day
44.35%
HV 20-Day
37.24%
HV 30-Day
36.03%
HV 60-Day
34.97%
HV Rank
69.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($17.00 target)
3
Strong Buy2
BuyData last updated: 4/30/2026